Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|October 3, 2013
Identification of transmembrane domain 3, 4 & 5 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptorXavier Sainsily, Jérôme Cabana, Philip E Boulais, et al.
Molecular Pharmacology|March 27, 2015
Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional SelectivityIvana Domazet, Brian J Holleran, Alexandra Richard, et al.
Biochemical Pharmacology|May 12, 2009
Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptorBrian J Holleran, Ivana Domazet, Marie-Eve Beaulieu, et al.
Biochemical Pharmacology|April 24, 2018
Angiotensin II cyclic analogs as tools to investigate AT1R biased signaling mechanismsDavid St-Pierre, Jérôme Cabana, Brian J Holleran, et al.
ACS Chemical Neuroscience|January 8, 2019
N-Guanidyl and C-Tetrazole Leu-Enkephalin Derivatives: Efficient Mu and Delta Opioid Receptor Agonists with Improved Pharmacological PropertiesJean-Louis Beaudeau, Véronique Blais, Brian J Holleran, et al.
Organic Letters|April 4, 2017
Synthesis and Evaluation of a 64Cu-Conjugate, a Selective δ-Opioid Receptor Positron Emission Tomography Imaging AgentAzadeh Pirisedigh, Véronique Blais, Samia Ait-Mohand, et al.
International Journal of Molecular Sciences|March 10, 2022
Monitoring TRPC7 Conformational Changes by BRET Following GPCR ActivationCécile Pétigny, Audrey-Ann Dumont, Hugo Giguère, et al.
Pageof 3